Appeal No. 1998-2267 Application 08/339,084 statements and evidence, Kaplowitz, cited by appellant which would reasonably appear to establish that NASH is distinct from the fatty liver condition described by Shironaga and the conditions described by Podda. After evidence or arguments are submitted by the appellant in response to rejection based on obviousness, patentability is determined on the totality of the record, by a preponderance of evidence with due consideration to persuasiveness of the argument. On balance, we believe that the totality of the evidence presented by the examiner and appellant weighs in favor of finding the claimed invention to be non-obvious in view of the cited references. We find the examiner has not established on the record before us that the cited references both suggest the claimed subject matter and reveal a reasonable expectation of success to one reasonably skilled in the art. The rejection of the claims for obviousness of the claimed invention is reversed. 7Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007